Pediatrix Medical Group
Staffs neonatal, maternal-fetal, obstetrical, and pediatric specialty care across US hospitals and practices.
Something off on this page? Send us feedback.
Profile
Provides hospital-based neonatal and pediatric physician services plus maternal-fetal and obstetrical care, earning patient-service revenue from insurers and government programs and administrative fees from hospitals. Neonatal care is the largest practice line, and operations depend on hospital contracts, clinician staffing, patient volumes, and reimbursement rules.
Provides neonatal, maternal-fetal and obstetrical, pediatric intensive-care, hospitalist, and pediatric surgical physician services across 37 US states. Affiliated clinicians staff and manage hospital units—especially neonatal intensive care units—and deliver office-based maternal-fetal care, while central infrastructure supports recruiting, credentialing, scheduling, billing, collections, clinical data, and quality programs. Patient-service fees from insurers and government programs drive most revenue, supplemented by administrative fees from hospital partners.
Neonatal care is the largest practice line, tying demand to births and medically complex deliveries. The network is concentrated in a handful of states, led by Texas, and relies on hospital contracts, clinician recruitment and retention, patient volumes, and effective revenue-cycle operations. Reimbursement is shaped by commercial payor contracts, Medicaid rates, the No Surprises Act, and other federal and state healthcare rules.
Company facts
Key statistics
Year to date +25.1% · Average volume (30d) 761.4K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Jefferies | Downgrade | Neutral | Hold | $27 | $28 |
| Aug 6, 2026 | UBS | Reiterate | Neutral | $25 | $28 | |
| Aug 5, 2026 | Deutsche Bank | Reiterate | Hold | $19 | $25 | |
| Jul 14, 2026 | Truist Financial | Target | $21 | $28 | ||
| May 12, 2026 | UBS | Reiterate | Neutral | $22 | $25 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026Q2 FY26 | $0.59 | $0.63 | +6.6% | $478.5M | $487.8M | +1.9% | −5.87% |
| May 5, 2026Q1 FY26 | $0.37 | $0.44 | +18.9% | $465.8M | $476.2M | +2.2% | +6.63% |
| Feb 19, 2026Q4 FY25 | $0.53 | $0.50 | −5.7% | $486.2M | $493.8M | +1.6% | −2.49% |
| Nov 3, 2025Q3 FY25 | $0.46 | $0.67 | +45.7% | $486.2M | $492.9M | +1.4% | +1.71% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $458.4M | $468.8M | $492.9M | $493.8M | $476.2M | $487.8M | |
| Gross profit | $102.6M | $124.7M | $140.3M | $120.4M | $113.0M | $132.5M | |
| Operating income | $32.1M | $59.9M | $68.1M | $54.7M | $46.6M | $56.9M | |
| Net income | $20.7M | $39.3M | $71.7M | $33.7M | $29.6M | $39.8M | |
| Diluted EPS | $0.24 | $0.45 | $0.84 | $0.40 | $0.36 | $0.49 | |
| Gross margin | 22.4% | 26.6% | 28.5% | 24.4% | 23.7% | 27.2% | |
| Operating margin | 7.0% | 12.8% | 13.8% | 11.1% | 9.8% | 11.7% |
Fiscal years (4-quarter sums)FY21 $1.91B · FY22 $1.97B · FY23 $1.99B · FY24 $2.01B · FY25 $1.91B
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $404.2M · Total debt $620.0M · Total assets $2.13B · Shareholders' equity $881.0M
Dividends
No dividends on record.
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 82.12M · Float 80.81M · 98.4% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 13.71M | 16.70% | 13F | Aug 7, 2026 |
| Rubric Capital Management LP | 8.28M | 9.64% | 13G | Nov 13, 2024 |
| Vanguard Portfolio Management LLC | 5.99M | 7.29% | 13F | Aug 13, 2026 |
| Dimensional Fund Advisors LP | 4.22M | 5.10% | 13G | Jul 14, 2026 |
| Vanguard Capital Management LLC | 3.62M | 4.41% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| May 13, 2026 | Shirley A. Weis | director | −36,028 | $23.75 |
| Dec 15, 2025 | Mark S. Ordan | director, officer: Chief Executive Officer | −23,000 | $22.41 |
| Nov 17, 2025 | Michael A. Rucker | director | −10,478 | $23.00 |
| Nov 6, 2025 | Laura A. Linynsky | director | −10,000 | $21.65 |
Peers
- HCA Healthcare
Hospital-network substitute for specialty physician contracts
- Tenet Healthcare
Hospital-system substitute across physician contracts and services
- Universal Health Services
Hospital-based substitute in obstetrics, pediatrics, and physician practices
- Community Health Systems
Community hospitals and employed physicians overlap core contracts
- UnitedHealth Group
Adjacent care-delivery platform with payer-channel leverage
- Privia Health
Physician enablement overlap in women's health and pediatrics
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Pediatrix Medical Group | $26.61 | −0.08% | $2.19B | 12.7 | 11.4 | 1.1 | +4.0% |
| HCA Healthcare | $417.82 | −0.00% | $90.46B | 14.0 | 13.6 | 1.2 | +8.7% |
| Tenet Healthcare | $266.80 | −0.05% | $21.48B | 10.3 | 13.0 | 1.0 | +6.8% |
| Universal Health Services | $172.00 | +0.09% | $10.39B | 7.0 | 7.4 | 0.6 | +8.3% |
| Community Health Systems | $2.94 | +0.17% | $413.2M | — | — | 0.0 | −9.8% |
| UnitedHealth Group | $392.50 | −0.12% | $356.86B | 25.3 | 18.4 | 0.8 | +0.4% |
| Privia Health | $20.79 | +0.10% | $2.62B | 95.9 | 54.4 | 1.1 | +21.4% |
| Median | 14.0 | 13.6 | 0.9 | +7.5% |